Kenneth J. Kelley, Director at HALOZYME THERAPEUTICS, INC. (HALO), sold 9,710 shares at $42.88 ($417K) on 2021-01-04, disclosed to the SEC on 2021-01-04.
Open-market sale of $417k HALO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.88 | 4,710 | $202K | 48.5% |
| 2 | $42.88 | 4,710 | $202K | 48.5% |
| 3 | $43.38 | 290 | $13K | 3.0% |
| Total | $42.89 avg | 9,710 | $417K | 100% |
| Filing → |
| HALO | SELL | 2021-02-01 | $469K | — | Filing → |
| HALO | SELL | 2020-12-07 | $1.4M | — | Filing → |
| HALO | SELL | 2020-12-02 | $1.3M | — | Filing → |